VC  HealthCare Ventures

     Office Locations:

47 Thorndike Street, SuiteB1-1
Cambridge, MA 02141
Phone: 617-252-4343



  • Early



  • Life Sciences & Healthcare



    Founded 1985, HealthCare Ventures (HCV) is a venture capital firm specializing in life science industry investing. The firm's target sectors include: target-focused cancer, infectious disease, cardiovascular disease, central nervous system disorders, immunomodulation and immunotherapy, novel manufacturing technologies, and novel lab scale instruments and reagents. The firm has raised over $1.6 billion in capital and has managed nine funds over the past twenty-five years. The fund's typical initial investments range between $1 million to $20 million in the form of equity or debt convertible to equity. HCV has invested in a total of 106 companies, 68 of which were start-ups.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Augustine Lawlor Managing Director
    Christopher K. Mirabelli Ph.D. Managing Director
    Douglas E. Onsi Venture Partner
    Harold R. Werner Co-Founder
    James H. Cavanaugh Ph.D. Managing Director


    Portfolio companies include:

        web link

        web link

        web link

      Apellis Pharmaceuticals
        web link

        web link

      Arresto BioSciences
        web link

      Ascent Therapeutics
        web link

      Bikam Pharmaceuticals
        web link

        web link

      Cellnovo Systems
        web link

      Cleveland HeartLab
        web link

        web link

      DecImmune Therapeutics
        web link

        web link

        web link

      Galleon Pharmaceuticals
        web link

      GITR Inc
        web link

        web link

      InfaCare Pharmaceutical
        web link

      Mosaic Biosciences
        web link

        web link

        web link

        web link

        web link

      Radius Health
        web link

      Seahorse Bioscience
        web link

        web link

        web link

        web link

        web link

      Tetra Logic Pharmaceuticals
        web link

      Theraclone Sciences
        web link

      Threshold Pharmaceuticals
        web link

        web link

        web link

        web link

        web link

        web link


    Recent News: